Actively Recruiting
Incidence of Residual Neuromuscular Blockade in Fraility in OncoGynae Surgery
Led by Mahidol University · Updated on 2025-05-08
622
Participants Needed
1
Research Sites
104 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Frailty among patients undergoing surgery is strongly associated with an elevated risk of adverse perioperative outcomes, heightened incidence of postoperative complications, increased mortality rates, and prolonged hospital length of stay. Our focus centers on investigating the frailty index in the context of complications experienced by patients undergoing oncologic gynecology surgery. The principal objective of this research is to elucidate the extent to which residual neuromuscular blocking agents are linked to frailty.
CONDITIONS
Official Title
Incidence of Residual Neuromuscular Blockade in Fraility in OncoGynae Surgery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age �38;= 18 years
- Patients undergoing elective gynecologic-oncology surgery
You will not qualify if you...
- Unable to communicate Thai
- Unable to understand the questionnaire
- Preexisting neuromuscular disease
- Preexisting disease involved wrist that may affect the nerve stimulator examination
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Anesthesiology department, Siriraj hospital, Mahidol University
Bangkok, Bangkok, Thailand, 10700
Actively Recruiting
Research Team
P
Patchareya Nivatpumin, M.D.
CONTACT
J
Jitsupa Nithiuthai, M.D.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here